This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

Pharmacotherapeutic Treatment Strategies for Antidepressant Nonresponse

Michael E. Thase, MD

Published: November 15, 2009

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Patients who do not respond to initial antidepressant treatment are more difficult to treat and have lower odds of remission than those who fully or partially respond to initial pharmacotherapy. Potential treatment options for nonresponders include combination and switching strategies, both of which can be done within a single class of medications or across medication classes. Choosing the correct strategy and appropriate pharmaceutical option or options requires consideration of not only algorithm recommendations, but also a variety of variables including, but not limited to, the patient’s symptom and side effect profiles.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...